Johnson & Johnson (NYSE:JNJ) ranks among the stocks to benefit from an onshoring boom. On July 23, Erste Group raised the ...

Johnson & Johnson (NYSE:JNJ) ranks among the best low volatility stocks to buy according to analysts. On July 16, Stifel ...

Johnson & Johnson N/A must pay more than US$42-million to a Massachusetts man who alleges that he developed mesothelioma, a ...

Johnson & Johnson MedTech (NYSE: JNJ) announced today that it launched its VirtuGuide AI-powered, patient-matched Lapidus ...

Biopharma giant Johnson & Johnson’s ($JNJ) stock hit new highs this year after reporting its Q2 results on July 16th, giving ...

Johnson & Johnson (NYSE:JNJ)’s shares are up by 5% since its latest earnings report, which saw it post $23.7 billion in sales ...

Johnson & Johnson's stock offers value with promising MedTech growth, raised guidance, strong dividends, and bullish ...

Johnson & Johnson (NYSE:JNJ) is one of the Most Undervalued High Quality Stocks to Buy According to Hedge Funds. On July 10, ...

Johnson & Johnson delivered a "beat and raise" quarter. Results were bolstered by the new acquisition of Intra-Cellular, ...

Johnson & Johnson (NYSE:JNJ) on Wednesday reported a second-quarter 2025 adjusted earnings of $2.77 per share, down 1.8% year ...

Johnson & Johnson (NYSE: JNJ) – Johnson & Johnson MedTech, a global leader in orthopaedic technologies and solutions, today ...

Johnson & Johnson earnings came in 3% higher than consensus. The company's operating leverage was "slightly diluted by higher ...